Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Halugen Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Halugen Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Halugen Life Sciences Today - Breaking & Trending Today
Entheon Biomedical Corp.: Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform
Improved Genetic Screening Platform to Strengthen Entheon's Psychedelic-Assisted Protocols Vancouver, British Columbia--(Newsfile Corp. - March 29, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB:
Source: finanznachrichten.de
Entheon Biomedical Corp.: Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today
Expanding brand awareness and access to HaluGen's Psychedelics Genetic Test Kit Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE:
Source: finanznachrichten.de
Entheon Biomedical Corp.: Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US
HaluGen Life Sciences' test evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) -
Source: finanznachrichten.de
Can a genetic test predict your response to psychedelic drugs?
1/2 HaluGen's psychedelic genetic test is currently on sale in Canada and the company expect to launch in the US later this year HaluGen 2/2 A new genetic test is claiming to predict a person's sensitivity to classical psychedelics such as psilocybin, but some researchers are skeptical With psychedelic-assisted psychotherapy on the cusp of broad clinical approval in the United States, there is a new pressing need to understand exactly which patients may be best suited to this novel treatment and which patients are most at risk of adverse reactions. Vancouver-b...
Source: newatlas.com